| CALUORI, Guido, Eva ODEHNALOVÁ, Tomasz JADCZYK, Martin PEŠL, Iveta PAVLOVÁ, Lucia VALÍKOVÁ, Steffen HOLZINGER, Veronika NOVOTNÁ, Vladimír ROTREKL, Aleš HAMPL, Michal CRHA, Dalibor ČERVINKA a Zdeněk STÁREK. AC Pulsed Field Ablation Is Feasible and Safe in Atrial and Ventricular Settings: A Proof-of-Concept Chronic Animal Study. Frontiers in bioengineering and biotechnology. Laussane: Frontiers Media S.A., 2020, roč. 8, DEC 2020, s. 1-14. ISSN 2296-4185. Dostupné z: https://dx.doi.org/10.3389/fbioe.2020.552357. |
Další formáty:
BibTeX
LaTeX
RIS
@article{1705356,
author = {Caluori, Guido and Odehnalová, Eva and Jadczyk, Tomasz and Pešl, Martin and Pavlová, Iveta and Valíková, Lucia and Holzinger, Steffen and Novotná, Veronika and Rotrekl, Vladimír and Hampl, Aleš and Crha, Michal and Červinka, Dalibor and Stárek, Zdeněk},
article_location = {Laussane},
article_number = {DEC 2020},
doi = {http://dx.doi.org/10.3389/fbioe.2020.552357},
keywords = {pulsed field ablation; irreversible electroporation (IRE); radiofrequency ablation; atrial fibrillation; ventricular arrhythmia (VA); preclinical cardiology},
language = {eng},
issn = {2296-4185},
journal = {Frontiers in bioengineering and biotechnology},
title = {AC Pulsed Field Ablation Is Feasible and Safe in Atrial and Ventricular Settings: A Proof-of-Concept Chronic Animal Study},
url = {https://www.frontiersin.org/articles/10.3389/fbioe.2020.552357/full},
volume = {8},
year = {2020}
}
TY - JOUR
ID - 1705356
AU - Caluori, Guido - Odehnalová, Eva - Jadczyk, Tomasz - Pešl, Martin - Pavlová, Iveta - Valíková, Lucia - Holzinger, Steffen - Novotná, Veronika - Rotrekl, Vladimír - Hampl, Aleš - Crha, Michal - Červinka, Dalibor - Stárek, Zdeněk
PY - 2020
TI - AC Pulsed Field Ablation Is Feasible and Safe in Atrial and Ventricular Settings: A Proof-of-Concept Chronic Animal Study
JF - Frontiers in bioengineering and biotechnology
VL - 8
IS - DEC 2020
SP - 1-14
EP - 1-14
PB - Frontiers Media S.A.
SN - 22964185
KW - pulsed field ablation
KW - irreversible electroporation (IRE)
KW - radiofrequency ablation
KW - atrial fibrillation
KW - ventricular arrhythmia (VA)
KW - preclinical cardiology
UR - https://www.frontiersin.org/articles/10.3389/fbioe.2020.552357/full
L2 - https://www.frontiersin.org/articles/10.3389/fbioe.2020.552357/full
N2 - Pulsed field ablation (PFA) exploits the delivery of short high-voltage shocks to induce cells death via irreversible electroporation. The therapy offers a potential paradigm shift for catheter ablation of cardiac arrhythmia. We designed an AC-burst generator and therapeutic strategy, based on the existing knowledge between efficacy and safety among different pulses. We performed a proof-of-concept chronic animal trial to test the feasibility and safety of our method and technology.
ER -
CALUORI, Guido, Eva ODEHNALOVÁ, Tomasz JADCZYK, Martin PEŠL, Iveta PAVLOVÁ, Lucia VALÍKOVÁ, Steffen HOLZINGER, Veronika NOVOTNÁ, Vladimír ROTREKL, Aleš HAMPL, Michal CRHA, Dalibor ČERVINKA a Zdeněk STÁREK. AC Pulsed Field Ablation Is Feasible and Safe in Atrial and Ventricular Settings: A Proof-of-Concept Chronic Animal Study. \textit{Frontiers in bioengineering and biotechnology}. Laussane: Frontiers Media S.A., 2020, roč.~8, DEC 2020, s.~1-14. ISSN~2296-4185. Dostupné z: https://dx.doi.org/10.3389/fbioe.2020.552357.
|
